n = 67 | |
---|---|
Age (years)a | 30.6 ± 8.4 |
Gender, n (%) | |
Male | 48 (71.6) |
Female | 19 (28.4) |
Treatment, n (%) | |
Lamivudine plus adefovir | 41 (61.2) |
Entecavir | 26 (38.8) |
ALT (IU/mL)a | 202.9 ± 137.9 |
HBV DNA (log10 IU/mL) | |
Daan Testa,b | 7.11 ± 0.44 |
Cobas TaqMana,b | 7.90 ± 0.73 |